Plain-English translation of NCT06529744 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are trying to build a better tool to predict how memory and thinking diseases will progress in people who are starting to show signs of cognitive changes. The study collects information from brain scans, blood and spinal fluid samples, skin biopsies, thinking tests, and behavioral questionnaires to create a model that could help doctors give more accurate predictions about disease progression.
Right now, doctors often struggle to predict exactly how quickly memory diseases will get worse in individual patients, which makes it hard to plan treatment and prepare for the future. This study aims to create a better predictive tool using biological markers that could help doctors give patients and families more reliable information about what to expect.
You likely qualify if…
You likely don't qualify if…
You would visit the study site for appointments where researchers collect blood samples, perform brain imaging scans (MRI), take a small skin biopsy, and have you complete thinking and memory tests plus questionnaires about your behavior and daily functioning. A study partner (family member or close friend) would also participate in some assessments to provide additional information about your cognitive and functional abilities. The study team will check your ability to consent at each visit and work with you to complete as many of these procedures as possible.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
Canada